Goleta Neighborhood Dental Clinic Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 164 Kinman Ave, Goleta, CA 93117 Phone: 805-617-7900 Fax: 805-617-7899 |
Goleta Dental Practice Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 164 Kinman Ave Ste B, Goleta, CA 93117 Phone: 805-683-7777 |
Santa Barbara Children's Dental Practice Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 6134 Calle Real, Ste B, Goleta, CA 93117 Phone: 805-681-7301 Fax: 805-681-7302 |
Steven G. Johnson Dental Corporation Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 7050 Hollister Ave Ste A-1, Goleta, CA 93117 Phone: 805-456-1235 |
Western Dental Services, Inc. Dentist Medicare: Not Enrolled in Medicare Practice Location: 5680 Calle Real, Goleta, CA 93117 Phone: 805-979-3040 Fax: 805-979-3041 |
Doran Dobranszky Dds Inc Dentist Medicare: Not Enrolled in Medicare Practice Location: 5901 Encina Rd Ste C1, Goleta, CA 93117 Phone: 805-967-5671 Fax: 805-967-5671 |
Huy Nguyen Dds Inc Dentist Medicare: Not Enrolled in Medicare Practice Location: 270 Storke Rd, Unit A, Goleta, CA 93117 Phone: 805-685-4400 |
News Archive
Patients with HER2-positive breast cancer, a particularly aggressive form of breast cancer, now have a new, effective and less toxic therapeutic option.
Teen-age boys exposed to pro-cannabis advertising and social media posts are more likely than female peers to associate marijuana use with improving sexual activity, new research from Washington State University suggests.
Chicken, turkey and pork sold in grocery stores harbors disease-causing bacteria known as Klebsiella pneumoniae, according to a new study. The research, which was published online today in the journal Clinical Infectious Diseases, shows that contaminated meat may be an important source of human exposure to Klebsiella.
Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that its subsidiary, Biovail Laboratories International SRL (BLS), has entered into an agreement with Santhera Pharmaceuticals (Switzerland) Ltd., a subsidiary of Santhera Pharmaceuticals Holding AG (SIX: SANN) to acquire the U.S. and Canadian rights to develop and commercialize Santhera's JP-1730/fipamezole for the treatment of Dyskinesia in Parkinson's Disease (DPD). JP-1730/ fipamezole is a first-in-class compound that, in a recent Phase IIb study, displayed the potential to reduce levodopa-induced dyskinesia.
Covidien, a leading global provider of healthcare products, today announced that the Solitaire FR revascularization device has been cleared by the U.S. Food and Drug Administration. The Solitaire FR device is intended to restore blood flow to the brain in patients suffering acute ischemic stroke by mechanically removing blood clots from blocked vessels.
› Verified 7 days ago